NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.47
+0.19 (1.33%)
Aug 18, 2026, 4:00 PM EDT - Market closed
NeuroPace Employees
NeuroPace had 220 employees as of March 31, 2026. The number of employees increased by 11 or 5.26% since the number was last reported on December 31, 2025.
Employees
220
Change
11
Growth
5.26%
Revenue / Employee
$486,332
Profits / Employee
-$86,882
Market Cap
496.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 220 | 11 | 5.26% |
| Dec 31, 2025 | 209 | 25 | 13.59% |
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 682 |
| Cerus | 275 |
| Sight Sciences | 186 |
| ClearPoint Neuro | 172 |
| 908 Devices | 172 |
| Delcath Systems | 156 |
NPCE News
- 7 days ago - NeuroPace Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - NeuroPace Earnings release: Q2 2026 - Filings
- 7 days ago - NeuroPace Quarterly report: Q2 2026 - Filings
- 7 days ago - NeuroPace Slides: Q2 2026 - Filings
- 7 days ago - NeuroPace reports Q2 EPS (18c), consensus (20c) - TheFly
- 7 days ago - NeuroPace raises FY26 revenue view to $99.5M-$101.5M from $99M-$101M - TheFly
- 7 days ago - NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance - Business Wire
- 20 days ago - NeuroPace: FDA seeks additional clinical evidence from NAUTILUS trial - TheFly